Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00385307 | Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS) | PHASE3 | COMPLETED | 680 | — | — | Sep 1, 2006 | Nov 1, 2007 | Mar 25, 2009 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| amibegron (SR58611A) | DRUG | - |
Inclusion Criteria: * Patient with Major Depressive Disorder diagnosed according to Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR * Patient meets criteria for a recurrent Major Depressive Episode (MDE) * Patient meets severity assessments of depression specified by the study Excl...